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Katsumi Imaizumi and Masao Sato*Abstract
Background: Exogenously hypercholesterolemic (ExHC) rats develop hypercholesterolemia and low hepatic
triacylglycerol (TAG) levels when dietary cholesterol is loaded. The responsible gene Smek2 was identified via
linkage analysis using the original strain Sprague–Dawley (SD) rats. In this study, we compared SD and ExHC rats to
investigate a relationship between hypercholesterolemia and the low hepatic TAG levels observed in ExHC rats.
Methods: Male 4-weeks-old ExHC and SD rats were fed a 1% cholesterol diet for 1 week. Serum and liver parameters
were analyzed. Gene expression and enzyme activities related to TAG metabolism were also assessed.
Results: We reproducibly observed higher serum cholesterol and lower hepatic TAG levels in ExHC rats than in SD rats.
Golgi apparatus in the livers of ExHC rats secreted β-very-low-density lipoprotein (β-VLDL) that had higher cholesterol
ester (CE) and lower TAG content than those in the β-VLDL secreted by SD rats. Gene expression related to fatty acid
and TAG synthesis in ExHC rats was lower than that in SD rats. Enzymatic activities for fatty acid synthesis were also
relatively lower in ExHC rats. Moreover, the fatty acid composition of hepatic and serum CE in ExHC rats showed
that these CEs were not modified after secretion from the liver despite the similar activities of serum
lecithin-cholesterol acyltransferase (LCAT) in ExHC rats to those in SD rats.
Conclusions: Low production of liver TAG and secretion of CE-rich, TAG-poor β-VLDL without modification by
LCAT in the circulation contributed to hypercholesterolemia induced by dietary cholesterol in ExHC rats.
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For decades, high serum total cholesterol has been iden-
tified as a clinical risk factor for atherosclerosis and car-
diovascular disease [1,2]. The factors that determine
serum total cholesterol levels are cholesterol synthesis in
the body, which is controlled by genetic expression [3,4],
and daily dietary intake [5,6]. Gene mutations related to
cholesterol metabolism have been detected mainly in the
region involved in serum lipoprotein metabolism [7]. As
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stated.dietary cholesterol, in whom serum cholesterol levels in-
crease more than those of normal subjects after a high-
cholesterol-diet period, have been reported by Katan
et al. [8]. However, the causes and mechanisms for regu-
lating sensitivity to dietary cholesterol remain unclear.
Exogenously hypercholesterolemic (ExHC) rats were estab-
lished from Sprague–Dawley (SD) rats as models for
diet-induced hypercholesterolemia [9]. Their serum total
cholesterol levels are increased only when fed a choles-
terol diet. ExHC rats do not develop aortic atherosclerosis
despite attempts to establish a model rat for atheroscler-
osis [9]. Clarification of responsible genes and pathogenic
mechanisms in ExHC rats will contribute to understandingLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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and hypercholesterolemia.
Several methods, including sib-pair analysis in human
populations [10], linkage mapping analysis in animal models,
and cholesterol-metabolic speculations [11], have been used
to scan responsible genes for determinants of serum choles-
terol concentration. We previously performed linkage ana-
lysis adapted to ExHC rats and found Smek2 as a gene
responsible for dietary cholesterol-induced hypercholes-
terolemia [12]. With this analysis, we established homo-
congenic Ex.BN-Dihc2 rats (congenic rats), in which the
responsible region for diet-induced hypercholesterolemia
on chromosome 14 was recombined to a genome derived
from brown Norway (BN) rats. Compared with ExHC
rats, congenic rats showed significantly higher hepatic tri-
acylglycerol (TAG) content as well as significantly lower
serum cholesterol levels [12]. However, the roles of Smek2
in lipid metabolism have not been defined. One report has
implicated Smek2 as well as Smek1 in the regulation of
gluconeogenesis [13]. Therefore, we investigated whether
ExHC rats had lipid metabolism phenotypes that displayed
known roles of Smek2. ExHC rats, as phenotypes, display
dietary cholesterol absorption and transport, hepatic chol-
esterol synthesis, and secretion similar to those of SD rats,
which were fed a cholesterol-containing diet [14]. Liver
cholesterol content in ExHC rats is identical to that in SD
rats, but TAG content in the liver is significantly lower in
ExHC rats than in SD rats [15]. Moreover, cholesterol se-
cretion in the range of d < 1.006 g/mL lipoproteins did not
differ between the two strains, whereas TAG secretion
levels in the range of d < 1.006 g/mL lipoproteins were sig-
nificantly lower in ExHC rats [14]. Compared with SD
rats, ExHC rats show decreased hepatic uptake of serum
cholesterol [14]; the rate of bile acid secretion into feces
is similar between the strains [14]. In general, cholesterol
intestinal absorption [14], hepatic synthesis [14], and ex-
cretion in feces [15] in ExHC rats are similar to those in
SD rats.
As described above, ExHC rats do not display typical
abnormalities in cholesterol metabolism. To elucidate the
mechanism underlying the increase in serum cholesterol
induced by dietary cholesterol in ExHC rats, we first in-
vestigated lipid metabolism in the liver, especially TAG
metabolism, by measuring the secretion of cholesterol
ester (CE)-rich β-very-low-density lipoprotein (β-VLDL).
To understand the abnormalities of lipid metabolism
in ExHC rats, we analyzed various phenotypes of lipid
metabolism in ExHC and SD rats. We investigated (1)
the composition of Golgi lipoprotein (d < 1.006 g/mL),
which is the composition of lipoproteins just before se-
cretion from the liver in both ExHC and SD rats; (2) the
activities of enzymes related to TAG metabolism (fatty
acid synthase [FAS], Mg2+-dependent phosphatidic acid
phosphohydrolase [PAP1], carnitine palmitoyltransferase[CPT], glucose 6-phosphate dehydrogenase [G6PDH]
and malic enzyme); (3) the hepatic messenger RNA
(mRNA) abundance related to lipid metabolism—acetyl-
coenzyme A [CoA] acyltransferase (Acat1), apolipoprotein
B (Apob), apolipoprotein E (Apoe), fatty acid translocase
(Cd36), CPT on mitochondrial inner membrane (Cpt1a),
Cpt2, diacylglycerol O-acyltransferase 1/2 (Dgat1/2), Δ5
fatty acid desaturase (Fads1), Δ6 fatty acid desaturase
(Fads2), fatty acid synthetase (Fasn), glycerol kinase (Gk),
glycerol-3-phosphate dehydrogenase 1 [soluble] (Gpd1),
microsomal triglyceride transfer protein (Mtp), LDL re-
ceptor (Ldlr), hepatic lipase (Lipc), lipolysis-stimulated
lipoprotein receptor (Lsr), phosphatidic acid phosphatase
type 2A (Ppap2a), stearoyl-CoA desaturase (Scd1), acyl-
CoA cholesterol O-acyltransferase (Soat1), sterol regula-
tory element binding transcription factor 1 (Srebf1), VLDL
receptor (Vldlr); and (4) the fatty acid composition of CE
in the serum and liver.
Materials and methods
Animals and diets
Male ExHC/Sea rat colonies have been maintained at
our institute through brother-sister mating. Male 24-days-
old SD/Sea rats were purchased from Seiwa Experimental
Animal Co., LTD. (Fukuoka, Japan). For analysis of serum
lipoprotein profile, male 24-days-old SD/Kud rats were
purchased from KYUDO Co., LTD. (Saga, Japan). These
animals had free access to a commercial nonpurified diet
(NMF, Oriental Yeast Co., Tokyo, Japan) and deionized
water and were maintained in a temperature-controlled
room at 22–25°C with a 12-h light cycle (0800–2200 h).
An experimental diet was formulated according to the
AIN76™ formula [16] (Table 1). In our previous report, we
affirmed that feeding a 1% cholesterol diet for 1 week in-
duced hypercholesterolemia [17]. After consuming the ex-
perimental diet for 1 week (at 5 weeks old), the rats were
killed via withdrawal of aortic blood under pentobarbitone
anesthesia. The liver was immediately excised for use in
subsequent experiments.
The handling and killing of all animals were carried
out in accordance with nationally prescribed guidelines,
and ethical approval for the experiments was granted by
the Animal Care and Use Committee, Kyushu University
(Kyushu University, Scientific Research Promotion Division;
authorization number: A22-160-2). In order to minimize
suffering, we performed arterial blood collection under
general anesthesia using subcutaneous sodium pento-
barbitone (Kyoritsu Seiyaku Corporation, Tokyo, Japan),
0.08 mg/100 g body weight.
Analysis of serum and liver parameters
Serum levels of cholesterol, TAG, non-esterified fatty
acid (NEFA, free fatty acid), glucose, and free glycerol
were measured with enzyme assay kits (Cholesterol C-





Mineral mixture (AIN76™) 35






Palmitic acid 16:0 10.1
Palmitoleic acid 16:1 0.6
Stearic acid 18:0 3.8
Oleic acid 18:1 80.7
Linoleic acid 18:2 4.1
α-linolenic acid 18:3 n-3 0.4
Eicosenoic acid 20:1 0.3
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Test: Wako Pure Chemical Industries, Osaka, Japan;
Glycerol Assay Kit: Cayman Chemical Company, Ann
Arbor, USA). Because amounts of glycerol generated via
hydrolysis of serum TAG were measured with an assay
kit (GPO-DAOS method [18]) to obtain serum TAG
levels, collected serum TAG levels were calculated from
measured TAG levels and serum free glycerol levels with
the following formula:
Collected TAG level (mg/dL) = measured TAG level
(mg/dL) – free glycerol level (mg/dL) × 885.4*/92.1**
(*molecular weight of glycerol trioleate (triolein), **mo-
lecular weight of glycerol). Lipoprotein profiles of pooled
blood serum obtained with the fast protein liquid chro-
matography method were analyzed using the Liposearch
analytical lipoprotein profiling service (Skylight Biotech,
Tokyo, Japan). Liver lipids were extracted using the
method described by Folch et al. [19] and measured as
total as well as free cholesterol, TAGs, and phospho-
lipids (Phospholipid B-Test was also purchased from
Wako Pure Chemical Industries).
Analysis of Golgi VLDL
Isolation of structurally intact Golgi compartments was
carried out using the method described by Swift et al.
[20] with some modifications [21]. Intact Golgi pellets
were resuspended in 1 mL of 154 mM NaCl and 15 mM
Tris–HCl (pH 7.4). This resuspended fraction was rap-
idly passed through a Teflon homogenizer twice. GolgiVLDLs were floated through saline (d = 1.006) via ultra-
centrifugation for 16 h at 100,000 × g in a 100.2 Beckman
rotor (Beckman Instruments, Palo Alto, CA, USA). Pro-
tein was measured using the method described by Lowry
et al. [22]. Lipids were extracted from the lipoproteins as
described by Folch et al. [19]. TAGs and phospholipids
were determined as described elsewhere [23]. CE and free
cholesterol were derivatized to trimethylsilyl ethers and
quantified with gas–liquid chromatography on a 3%
OV-17 column (GL Sciences, Tokyo, Japan) with 5α-
cholestane (Nacalai Tesque, Kyoto, Japan) as an in-
ternal standard [24].
Determination of hepatic mRNA levels
Total cellular RNA was isolated from liver tissue using a
guanidinium thiocyanate/cesium chloride ultracentrifu-
gation method according to Chirgwin et al. [25]. Com-
plementary DNA was synthesized from 1.0 μg total RNA
using a Transcriptor First Strand cDNA Synthesis Kit
(Roche, Berlin, Germany). Expression levels for 23 genes
related to lipid metabolism were analyzed using quanti-
tative real-time reverse transcription polymerase chain
reaction with a SYBR Premix EX Taq II kit and a Thermal
Cycler Dice Real Time System TP800 (Takara, Shiga,
Japan). The mRNA levels were normalized using the β-
actin gene as an internal standard. Primer sequences for
the analysis are shown in Table 2.
Determination of enzyme activity
Two grams of liver was homogenized in 6 volumes of a
0.25 M sucrose solution containing 1 mM ethylenedi-
aminetetraacetic acid (EDTA) in 10 mM Tris–HCl buf-
fer (pH 7.4). After precipitating the nuclei fraction, the
supernatant was centrifuged at 10,000 × g for 10 min at
4°C to obtain mitochondria. The resulting supernatant
was centrifuged again at 125,000 × g for 60 min at 4°C to
precipitate microsomes, and the remaining supernatant
was used as the cytosol fraction. The mitochondrial and
microsomal pellets were resuspended in 0.25 M sucrose
solution containing 1 mM EDTA in 10 mM Tris–HCl
buffer (pH 7.4).
The activities of CPT in the liver mitochondrial frac-
tion and Mg2+-dependent PAP1 in the liver microsomal
fraction were determined as described by Markwell et al.
[26], and by using a modified version [27] of the method
described by Walton et al. [28], respectively. FAS activity
was determined as described by Kelley et al. [29], G6PDH
activity was measured using the method described by
Kelley et al. [30], and the activity of malic enzyme in the
liver cytosol fraction was determined as described by
Ochoa [31]. Activities of β-oxidation in the liver peroxi-
somal fraction were measured using the method described
Table 2 Primers for real-time RT-PCR
Gene Forward primer Reverse primer Product (bp)
Actb TCAGGTCATCACTATCGGCA TCATGGATGCCACAGGATTC 93
Mtp CGACGGTGACGATGATCAACT TGACCCGCATTTTCGACATT 66
Apob ACAACCCTCACGGTCTTTGG GAGACACGATCTGGAACTTG 171
Apoe AGGAGCAGACCCAGCAGATA GGAGTTGGTAGCCACAGAGG 143
Fasn ATGCACACAGTGCTCAAAGG GTATCCTCCACAGGCAGGAA 227
Scdl GAGATACACTCTGGTGCTC AAGGCGTGATGGTAGTTGTGG 156
Fads1 TCAGCGGAAGAAATGGGTG GGATATGGTTCATCTGCGTCA 167
Fads2 TTGTCCTTGGAGAGTGGCAG GTACATAGGGATGAGCAGCG 119
Dgat1 GATGCTCTTTTTCACCCAGC GAGACGCTCAATGATTCGTG 118
Dgat2 CTGGCTGGCATTTGACTGGA CTGGATGGGAAAGTAGTCTCG 108
Gk GAATCCCACTCAGCCATTTG TCCTAGAGCAGTTGTCTCGG 128
Gpdl CAAACACCCAACTTCCGCATC CAGCCCCAACAGCCACTATA 91
Ppap2a GCGATGGCTACATTGAGAAC GGCTTGAAGATAAAGTGCGAC 134
Srebf1 ATGCCATGGGCAAGTACACA ACGTGTCAAGAAGTGCAAGG 179
Cptla AAGGTGCTGCTCTCCTACCA GGCCTCACAGATTCCAGGTA 193
Cpt2 TGACAGCCAGTTCAGGAGAA ATACTCAGACTTTGGGTCCG 217
Soat1 GATGGGGTTATGTTGCTATGC GGGCTCCTGTTTGATATTCCG 113
Acat1 CAGGTCTACCCATTGCCACT CCCACCGTATGGTGTTGCTC 185
Ldlr CACTGTGGCAGTAGTGAGTG GGCTACCGTGAATACAGGAG 151
Vldlr CCGTTCTACTCAGTGTATCCC CGTCACAGTCATCCTGTCCA 176
Lipc ACTCTTCCTCATCACCCGAG CGCTGTTTTCCCACTTGAAC 257
Lsr GAGGGTCCTATACTATATGGAG TGGAGGGAGGTTACTTCACTC 108
Cd36 GAAGCACTGAAGAATCTGAAGAG TCCAACACCAAGTAAGACCATC 159
Smek1 GAGCGACGGTTCTCTTCTTC CAGACCACACAATCAGAGTGTC 86
Smek2 CTGCATATCAGAAGCAGCAG ACTGATGGGTCCTTACCTTG 142
Gene symbols: Acat1, acetyl-CoA acyltransferase; Apob, apolipoprotein B; Apoe, apolipoprotein E; Cpt1a, CPT on mitochondrial outer membrane; Cpt2, CPT on mitochondrial
inner membrane; Dgat1/2, diacylglycerol O-acyltransferase 1/2; Fads1, Δ5 fatty acid desaturase; Fads2, Δ6 fatty acid desaturase; Fasn, fatty acid synthetase; Gk, glycerol
kinase; Gpd1, glycerol-3-phosphate dehydrogenase 1 (soluble); Mtp, microsomal triglyceride transfer protein; Ppap2a, phosphatidic acid phosphatase type 2A; Scd1,
stearoyl-coenzyme A (CoA) desaturase; Srebf1, sterol regulatory element binding transcription protein 1; Soat1, acyl-CoA cholesterol acyltransferase. Uptake: Cd36, fatty
acid translocase; Ldlr, low-density lipoprotein receptor; Lipc, hepatic lipase; Lsr, lipolysis-stimulated lipoprotein receptor; Smek1/2, homolog 1/2, suppressor of mek1
(Dictyostelium); Vldlr, very-low-density lipoprotein receptor.
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(LCAT) activity was measured with enzyme assay kits
(ANASOLV® LCAT, SEKISUI Medical Co. LTD., Tokyo,
Japan) [33].
Analysis of fatty acid compositions of serum and liver CE
Lipid samples extracted from the serum and the liver
were separated with thin-layer chromatography, and CE
tractions were obtained. Fatty acid composition was ana-
lyzed using gas–liquid chromatography (GC8A, Shimadzu,
Kyoto, Japan) on an Omegawax 320 capillary column
(Supelco, Japan, Tokyo) as described elsewhere [34]. Pat-
tern similarities of fatty acid composition between serum
and liver CE were calculated. Pattern similarity was
defined as “the index of product sum of componentsstandardized by square roots of sum of squares of each
component, when 2 samples are regarded as vectors (A =
[a1, a2, …, an], B = [b1,b2, …, bn])” and calculated with the
following:










Data for each measurement (n = 5/group) were analyzed
through inspection of all differences using the Student’s
t-test with Excel 2010 (Microsoft, Redmond, USA) and
the add-in software Statcel 3. Differences were consid-
ered significant when p was <0.05.
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Growth parameters
As the result of matching in age, initial body weights,
and hence final body weights of ExHC rats were signifi-
cantly lower than those of SD rats (Table 3). Body weight
gain, total food intake, food efficiency, relative liver weight
were similar between the strains (Table 3). Judging from
the similar total food intake, total cholesterol intakes were
similar between the strains.
Serum and liver parameters and serum lipoprotein profile
As shown in Figure 1, serum cholesterol levels in ExHC
rats were higher than those in SD rats, whereas ExHC and
SD rats showed similar levels of liver total and free choles-
terol. Conversely, ExHC and SD rats showed similar serum
TAG levels, whereas ExHC rats had lower liver TAG levels.
ExHC and SD rats did not differ in serum glucose and liver
phospholipid levels. Serum NEFA and free glycerol levels in
ExHC rats were significantly higher than those in SD rats.
The serum lipoprotein profile in SD and ExHC rats
are shown in Figure 2. These profiles were similar in the
2 strains before the cholesterol-containing diet was fed
(at 4 weeks of age). By contrast, ExHC rats showed
higher cholesterol levels in the VLDL + LDL fraction
(mainly VLDL) after consuming a cholesterol-containing
diet (at 5 weeks of age).
Composition of lipoprotein (d < 1.006) secreted from
Golgi apparatus
Although the proportions of free cholesterol and phos-
pholipids in lipoprotein (d < 1.006) secreted from Golgi
apparatus did not differ between strains, the proportions
of CE and protein were increased and TAG was decreased
in ExHC rats (see Figure 3). Therefore, the ratio of CE to
TAG in lipoprotein in ExHC rats was 4 times that in SD
rats (SD: 0.1 ± 0.0; ExHC: 0.4 ± 0.0; p < 0.05).
mRNA expression of lipid metabolism–related genes in
the liver
Figure 4 shows the mRNA expression of lipid metabolism–
related genes in the liver. Genes related to lipid secretion—Table 3 Growth parameters
SD ExHC
Initial body weight (g) 113.5 ± 4.2 95.8 ± 2.5**
Final body weight (g) 163.6 ± 2.1 143.6 ± 3.2**
Body weight gein (g) 50.2 ± 3.7 47.9 ± 4.1
Food intake (g) 97.0 ± 0.0 97.2 ± 3.3
Food efficiency (g body
weight gein/g food intake)
0.517 ±0.038 0.492 ± 0.038
Liver weight (g/100 g body weight) 4.42 ± 0.13 4.56 ± 0.07
Values are mean ± standard error of the mean (SEM); n = 5. **p < 0.01.
ExHC, exogenously hypercholesterolemic; SD, Sprague–Dawley.Mtp, Apob, and Apoe—in the liver of ExHC rats were
expressed at the same levels as those in SD rats. mRNA
levels of Fasn and Scd1 in ExHC rats were significantly
lower than those in SD rats, and that of Fads2 also tended
to be lower (p = 0.09) in ExHC rats, but the expression of
some genes related to TAG and fatty acid synthesis—
Fads1, Dgat1/2, Gk, Ppap2a, Srebf1 —were similar be-
tween the 2 strains. Furthermore, the mRNA level of
Gpd1 was decreased in ExHC rats. In gene expression re-
lated to TAG and fatty acid catabolism, Cpt1a and Acat1
mRNA levels were significantly decreased in ExHC rats.
Cpt2 and Soat1 mRNA levels did not differ between
strains. In a group of genes related to lipid uptake by
the liver, the level of Vldlr mRNA in ExHC rats was
twice that in SD rats. Lipc, Ldlr (LDL receptor), Lsr, and
Cd36 mRNA expression levels were similar between the
2 strains.
Activities of serum LCAT and enzymes related to TAG
metabolism in the liver
As shown in Table 4, FAS activity in the hepatic cyto-
solic fraction of ExHC rats was significantly lower than
that in SD rats. The activity of CPT in ExHC rats was
higher than that in SD rats. The activity of peroxisomal
β-oxidation of fatty acids in ExHC rats was lower than
that in SD rats. No differences in malic enzyme activity,
G6PDH in the hepatic cytosolic fraction, PAP1 in the
hepatic microsomal fraction, or serum LCAT occurred
between the 2 strains.
Fatty acid composition of serum and liver CE
In the fatty acid composition of serum CE, proportions
of palmitic acid, stearic acid, oleic acid, and linoleic acid
were increased in ExHC rats compared with those in SD
rats, and the proportion of arachidonic acid was de-
creased in ExHC rats. Conversely, in liver CE, the pro-
portion of linoleic acid was increased and proportions of
palmitic acid, palmitoleic acid, and arachidonic acid were
decreased in ExHC rats (see Figure 5A,B).
The pattern similarity of the fatty acid composition in
hepatic and serum CE in ExHC rats had a higher score
at 0.9919 than that in SD rats at 0.5767. Pattern similarity
between the hepatic CE fatty acid compositions in both
strains was 0.9911 (see Figure 5C,D).
Discussion
After being fed a cholesterol-containing diet, ExHC rats
developed hypercholesterolemia and displayed low liver
TAG content (see Figure 1). This hepatic TAG reduction
was due to reduced enzyme activities such as those of
FAS (see Table 4) related to fatty acid synthesis as a
result of decreasing mRNA levels (see Figure 4). This re-
duction of liver TAG content led to a decline in the pro-
portion (wt%) of TAG in all constituents of lipoprotein
Figure 1 Serum and liver parameters in rats. (A–E) Serum parameters (A: total cholesterol; B: triacylglycerol [TAG]; C: glucose; D: non-esterified
fatty acid [NEFA]; and E: free-glycerol) in Sprague–Dawley (SD/Sea; solid bar) and exogenously hypercholesterolemic (ExHC; open bar) rats were
measured with enzyme assay. Rats were fed a cholesterol-containing diet for 1 week. In (B), serum TAG levels represent collected TAG levels
calculated with the formula given in the Analysis of Serum and Liver Parameters section in the Materials and Methods. (F–H) Liver lipids (F: total
and free cholesterol; G: TAG; H: phospholipids) in SD (solid bar) and ExHC (open bar) rats were extracted using the method described by Folch
et al. [19] and measured with enzyme assays. TC and FC in (F) refer to total cholesterol and free cholesterol, respectively. Values are mean ± standard
error of the mean (SEM); n = 5; **p < 0.01.
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Figure 3). We have reported that the amount of choles-
terol secreted by the liver in ExHC rats is identical to that
secreted by the livers of SD rats [17]. Taken together, the
CE/TAG ratio in VLDL of ExHC rats significantly in-
creases with decreases in hepatic TAG secretion, and the
lipoprotein secreted by ExHC rats is a CE-rich VLDLFigure 2 Serum lipoprotein profiles of cholesterol and triacylglycerol
chromatography fractions of pooled blood serum from SD/Kud (dash line)
cholesterol-containing diet) and (B) at 5 weeks of age (after being fed the(defined as β-VLDL). Hepatic intake of β-VLDL is delayed
in ExHC rats because the affinity of β-VLDL for LDL re-
ceptors in ExHC rats is low [34]. In ExHC rats, this delay
slows catabolism and β-VLDL retention and causes a se-
quential increase in serum total cholesterol levels. This
process is the pathogenic mechanism of hypercholesterol-
emia in ExHC rats, and this serum cholesterol–regulated. Cholesterol (upper) and TAG (lower) profiles in fast protein liquid
and ExHC (solid line) rats (A) at 4 weeks of age (before being fed a
cholesterol-containing diet for 1 week).
Figure 3 Composition (wt%) of Golgi lipoprotein (d < 1.006)
from SD and ExHC rats. Composition (wt%) of Golgi lipoprotein
(d < 1.006) from SD/Sea (inside) and ExHC (outside) rats was analyzed
using the Lowly method (proteins) and gas–liquid chromatography
(lipids). Values are means ± SEM; n = 5. *p < 0.05. CE, cholesterol ester;
FC, free cholesterol; PL; phospholipid; TAG, triacylglycerol.
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reported. In ExHC rats, hepatic TAG decrease leads
to serum cholesterol elevation only when cholesterol is
included in the diet. Furthermore, we have previously
reported that a high linoleic safflower oil- and cholesterol-
containing diet increases hepatic TAG levels and amelio-
rates hypercholesterolemia in ExHC rats compared with
the effects of an olive oil– and cholesterol-containing diet
[35]. These changes related to differences in dietary fatty
acids were not observed in SD rats. These data also sup-
port an inverse relationship between hepatic TAG levels
and hypercholesterolemia in ExHC rats.
Hepatic TAG levels are regulated by (1) quantitative
and qualitative intake of dietary TAG, (2) TAG synthesis,Figure 4 Hepatic messenger RNA expression levels in SD and ExHC ra
ExHC rats were measured using real-time reverse transcription-polymerase
data were set relative to SD rats. Values are means ± SEM; n = 5. *p < 0.05; *
the primers used.(3) catabolism, and (4) VLDL secretion. In a comparison
of mRNA abundance in the liver in ExHC and SD rats,
the lower expression levels of genes for fatty acid synthe-
sis were particularly important. In addition, FAS activity
was lower, and mRNA levels of Scd1, a modification en-
zyme for fatty acids, were decreased in ExHC rats. Srebf1
codes SREBP-1c which is one of transcriptional factors
and regulates FAS mRNA [36], its mRNA expression
levels were similar between the 2 strains (see Figure 4).
The behavior of SREBP-1c in cells are regulated by many
post-translational modification of phosphorylation and
ubiquitination, and so on [37,38]. Judging from these in-
formations, the decreases in mRNA levels of genes re-
lated to de novo fatty acid synthesis in ExHC rats might
be a result of hypoactive SREBP-1c behavior. The de-
creases in FAS activities suggested that de novo fatty acid
synthesis is lower in ExHC rats, decreasing TAG synthe-
sis. Moreover, the mRNA level of glycerol-3-phosphate
dehydrogenase, which supplies glycerol-3-phosphate as a
TAG synthesis substance, was lower in ExHC rats. De
novo fatty acids and glycerol-3-phosphate are derived
from glucose. These data suggested that glucose metab-
olism in ExHC rats is abnormal. Smek2, identified as a
gene responsible for hypercholesterolemia induced by
dietary cholesterol in ExHC rats, reportedly involves glu-
coneogenesis [13]. Another determinant of hepatic TAG
levels is fatty acid catabolism. In ExHC rats, peroxisomal
β-oxidation was significantly lower, and mitochondrial
CPT activities were significantly higher compared with
those of SD rats (Table 4). The decrease in peroxisomal
β-oxidation, which mainly shortens long-chain (>C18:0)
fatty acids, may reflect a decline in long-chain fatty
acids, as demonstrated by the low proportion of C20:4
in hepatic CE (Figure 5A). The increase in mitochondrial
CPT activities implied a high level of mitochondrial β-
oxidation. Therefore, along with the low FAS activities,ts. Hepatic messenger RNA (mRNA) expression levels in SD/Sea and
chain reaction. The β-actin gene was used as an internal control, and
*p < 0.01. See Table 2 for a key to the abbreviations and sequences of
Figure 5 Fatty acid composition of cholesterol ester in serum and liver
(CE) in (A) liver and (B) serum of SD/Sea (solid bar) and ExHC (open bar) rats
*p < 0.05. (C,D) Comparison of fatty acid composition between liver CE (dash
Table 4 Activities of hepatic enzymes and serum LCAT
activity in SD and ExHC rats
SD ExHC
Liver enzyme activities nmol mn-1 mg-1 protein
Fatty acid synthase 37.8 ± 2.9 29.5 ± 2.1*
Malic enzyme 83.2 ± 6.1 81.6 ± 10.1
Glucose 6-phosphate dehydrogenase 90.9 ± 10.0 87.7 ± 18.4
Phosphatidate phosphohydrolase
Mg2+-dependent 17.4 ± 0.6 15.7 ± 1.1
Carnitine palmitoyl transferase 1.42 ± 0.13 2.52 ± 0.21*
Peroxisomal β-oxdation 9.40 ± 1.39 3.92 ± 0.75*
Serum enzyme activity Unit ┼
LCAT 268 ± 22 251 ± 39
Values are mean ± SEM; n = 5. *p < 0.05. ExHC, exogenously
hypercholesterolemic; SD, Sprague–Dawley.
✝Unit of lecithin:cholesterol acyltransferase (LCAT) activity is defined as a
concentration of esterified free-cholesterol at 37°C in 1 h in the operating
manual of the ANASOLV® LCAT (SEKISUI Medical Co. LTD., Japan).
Abbreviations: LCAT lecithin:cholesterol acyltransferase.
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TAG content in ExHC rats.
Cholesterol metabolism has been analyzed in detail in
ExHC rats [14,15,17,39]. Cholesterol intestinal absorp-
tion [14], hepatic synthesis [39], and excretion in feces
[15] in ExHC rats are similar to those in SD rats. We
have also reported that when ExHC rats are fed a chol-
esterol diet, the uptake of blood β-VLDL by the liver is
lower in ExHC rats compared with that in SD rats fed a
cholesterol diet because both the association and the
degradation of β-VLDL by the liver cells is lower in
ExHC rats [17]. In this study, the mRNA levels of
Ldlr and Lsr in ExHC rats did not differ from those
in SD rats (see Figure 4). Cd36 and Lipc mRNA
levels, which relate to fatty acid uptake, were also not
different. Among genes for which expression levels were
measured, the mRNA level of Vldlr in ExHC rats was
significantly higher than that of SD rats. Although
the mechanism is unclear, serum VLDL reportedlyof SD and ExHC rats. (A,B) Fatty acid composition of cholesterol ester
was analyzed with gas chromatography. Values are means ± SEM; n = 5.
ed line) and serum CE (solid line) in (C) SD rats and (D) ExHC rats.
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cell line [40]. The increase of Vldlr mRNA level seems
to be due to the increase of VLDL particles or chemical
components of β-VLDL. In other words, the increase of
VLDL particles in ExHC rats might increase Vldlr
mRNA levels. Additionally, the amount of LDL receptor
protein in the liver was similar in the 2 strains [15].
Briefly, the delay in hepatic β-VLDL uptake was not
caused by the amounts of receptor proteins and mRNA.
Huff et al. [41] have reported that β-VLDL has an abun-
dance of not only CE but also apolipoprotein E (apoE).
ApoE-rich β-VLDL shows high affinity for LDL recep-
tors and is taken up by liver cells [42]. However, we have
shown that serum apoE levels are similar between ExHC
and SD rats fed cholesterol [15]. Despite the β-migration
of VLDL caused by low TAG synthesis in ExHC rats,
serum apoE levels were not higher, which delayed hep-
atic uptake of β-VLDL in ExHC rats.
In order to obtain the evidence of delayed β-VLDL ca-
tabolism in ExHC rats, we investigated the fatty acid
composition of serum and hepatic CE. The hepatic and
serum CE fatty acid compositions in SD rats were dis-
similar. We calculated pattern similarity between these
compositions with a value of 0.5767 in these rats (see
Figure 5C). However, hepatic and serum fatty acid com-
positions in ExHC rats were highly similar and displayed
a value of pattern similarity of 0.9919 (see Figure 5D).
Moreover, we calculated pattern similarity between
hepatic CE fatty acid compositions in both strains, and
the value was 0.9911. These values imply that ExHCFigure 6 Pathogenic mechanism of hypercholesterolemia in ExHC rat
arrows represent increases and decreases in phenotypes of ExHC rats compar
and cholesterol ester, respectively.and SD rats have highly similar hepatic CE fatty acid
compositions, and only SD rats display modified CEs
after secretion. The CE pool in the lipoprotein particles
in SD rats may frequently undergo fatty acid transport
by LCAT in the circulation. However, serum LCAT ac-
tivities were the same in the 2 strains (see Table 4). The
high CE/TAG ratio in the serum lipoprotein of ExHC
rats might inhibit the modification of CEs by LCAT in
the circulation.
We measured serum glucose and free glycerol levels.
Although serum glucose levels were similar between the
2 strains, serum free glycerol levels in ExHC rats were
significantly higher than those in SD rats (see Figure 1C, E).
Free glycerol in blood derives from lipolysis in the
blood by lipoprotein lipase and in adipose tissues via
hormone-sensitive lipase. Free glycerol is taken up by
the liver as a substrate of gluconeogenesis and TAG syn-
thesis. Glycerol metabolism is mediated by insulin, which
suppresses glycerol emission from adipose tissues and gly-
cerol uptake by the liver [43]. However, Kiriyama et al. [44]
have reported that glycerol metabolism is not suppressed
in db+/db +mice despite their hyperinsulinemia. More-
over, lipolysis in adipose tissue and gluconeogenesis in the
liver are facilitated in these mice. The abnormality in gly-
cerol metabolism in ExHC rats may involve an increase in
serum NEFA levels and a decrease in hepatic mRNA ex-
pression of Gpd1 encoding glycerol-3-phosphate dehydro-
genase 1. Glycerol is supplied and catabolized in glucose
metabolism. Also, NEFA behavior in serum relates to glu-
cose metabolism. Additionally, it has been reported thats. Directional lines represent chronology of events. Black and gray thick
ed with those of SD rats, respectively. TAG and CE refer to triacylglycerol
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gluconeogenesis via dephosphorylation of cyclic adenosine
monophosphate–response element binding protein-regulated
transcriptional coactivator 2 as regulatory subunits of protein
phosphatase 4 [13]. We hypothesize that the elevation
in serum cholesterol levels in ExHC rats is caused by
a decrease in hepatic TAG synthesis, which may be caused
by delayed glucose metabolism controlled by Smek2. Fur-
ther investigation of glucose metabolism in ExHC rats
is needed.
In conclusion, we illustrated the pathogenic mechan-
ism of hypercholesterolemia in ExHC rats (Figure 6).
This study demonstrates that decreases in hepatic TAG
synthesis in ExHC rats leads to hepatic secretion of CE-
rich, TAG-poor β-VLDL. The production of these abnor-
mal particles depends on decreases in hepatic fatty acid
and TAG syntheses. In addition, the similarity in fatty
acid composition between serum and hepatic CE in
ExHC rats indicates that the behavior of circulatory CE
is unaffected by modification. To gain insights into these
observations, we must grasp glycometabolism in ExHC
rats and investigate the involvement of Smek2 in lipid
metabolism.
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